Relmada Therapeutics, Inc. (RLMD) Analyst Forecast

NASDAQ Currency in USD Disclaimer

Add to Alerts ADD TO LIST

south_east

-$0 (-1.27%)

Day's range

$0.25

$0.28

Date	Brokerage Firm	Analyst Name	Price Target	Price when Posted	Upside/Downside on Report Date
06/04/2024	Goldman Sachs	Andrea Tan	$2.00	$2.95	-32.2%
10/13/2022	Jefferies	Andrew Tsai	$8.00	$6.48	23.55%
10/13/2022	Oppenheimer	Jay Olson	$7.00	$6.75	3.73%

Relmada Therapeutics, Inc. FAQ's

Relmada Therapeutics, Inc. has been rated by research analysts at Goldman Sachs, Jefferies, Oppenheimer in the past 90 days.